Breaking Finance News

Johnson & Johnson (NYSE:JNJ) stock price target increased to $117.64, issued a research note today by Vetr Inc.

In a statement issued on 11/29/2016 Vetr Inc. bumped up the target of Johnson & Johnson (NYSE:JNJ) to $117.64 stating a potential upside of 0.05%.

On 2/5/2016, Credit Suisse released a statement on Johnson & Johnson (NYSE:JNJ) dropped the target price from $108.00 to $106.00 that suggested an upside of 0.05%.

Having a price of $112.52, Johnson & Johnson (NYSE:JNJ) traded -0.52% lower on the day. With the last close down -4.94% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the same period. Johnson & Johnson has recorded a 50-day average of $115.97 and a two hundred day average of $118.40. Volume of trade was down over the average, with 2,794,061 shares of JNJ changing hands under the typical 6,833,040

Performance Chart

Johnson & Johnson (NYSE:JNJ)

With a total market value of $0, Johnson & Johnson has price-earnings ratio of 19.76 with a one year low of $94.28 and a one year high of $126.07 .

A total of 18 analysts have released a report on Johnson & Johnson. zero analysts rating the company a strong buy, zero analysts rating the company a buy, zero analysts rating the company a hold, zero analysts rating the company a underperform, and finally zero analysts rating the company a sell with a 12-month price target of $117.44.

More About Johnson & Johnson (NYSE:JNJ)

Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. The Company's segments include Consumer, Pharmaceutical and Medical Devices. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on over five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.